Loading patent…
AssigneeKorea Basic Science Institute
InventorsGun-Hwa Kim, Soohyun Kim, Jong-Soon Choi, Seung II Kim, Edmond Changkyun Park
Estimating the term…
The present invention relates to a pharmaceutical composition for preventing or treating diabetes or fatty liver, and more specifically relates to a pharmaceutical composition for preventing or treating diabetes or fatty liver containing a CYP4A (cytochrome P450A) inhibitor as an active ingredient. According to the present invention, the CYP4A inhibitor suppresses endoplasmic reticulum stress, reduces the blood insulin concentration and suppresses apoptosis of liver cells, and hence exhibits effects in preventing or treating diabetes or fatty liver.
A pharmaceutical composition for preventing or treating diabetes or fatty liver comprising a CYP4A. (cytochrome P450 4A) inhibitor as an active ingredient.
A method for treating diabetes or fatty liver, comprising administering to a subject in need thereof an effective amount of a CYP4A inhibitor.
Use of a CYP4A inhibitor o the preparation of an agent for a diabetes or fatty liver.
Dependencies are inferred from the claim text.